FDA Grants Breakthrough Therapy Designation to Olomorasib for Advanced Pancreatic Cancer
The U.S. FDA has granted Breakthrough Therapy designation to Lilly's investigational KRAS…
New Phase III Data Shows Survival Benefit in Advanced Gastric Cancer
AstraZeneca reports positive Phase III CLARITY-Gastric01 results showing sonesitatug vedotin significantly improves…
New Research Collaboration Aims to Advance Personalized Cancer Treatment
GE HealthCare and Mayo Clinic have launched the MI-BET research collaboration to…
WHO Warns Global Cancer Cases Could Nearly Double by 2050
WHO has warned that global cancer cases could nearly double by 2050,…
Global Oncology Pipeline Set to Expand With Next-Generation Cancer Drug Innovation
Novartis will acquire UK-based Myricx Bio in a deal worth up to…
Strategic Collaboration to Accelerate AI-Powered Cancer Research
The Department of Health – Abu Dhabi and the MIT Koch Institute…
UAE oncology experts gather to unpack latest global cancer research
SEHA's Tawam Hospital has launched the Best of ASCO 2026 UAE programme…
Boehringer Ingelheim launches three phase III trials in precision Oncology
Boehringer Ingelheim has initiated three Phase III clinical trials aimed at advancing…
LCRF and AstraZeneca Launch Research Awards to Advance Small Cell Lung Cancer Treatment
The Lung Cancer Research Foundation (LCRF), in collaboration with AstraZeneca, has announced…
Harbour BioMed Announces NMPA Acceptance for the Treatment of Advanced Solid Tumors
Harbour BioMed has announced that China’s National Medical Products Administration (NMPA) has…
